1. Australia Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Sonic Healthcare Limited

Sonic Healthcare Limited

SHL.AX
Sonic Healthcare LimitedAU flagAustralian Securities Exchange
21.77
AUD
+0.23
- -
10.76BMarket Cap
Sonic Healthcare Limited
SHL.AX
(Australian Securities Exchange)

Recent

price

21.77

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
7.59
7.89
8.48
8.67
9.63
10.32
12.05
12.13
12.97
13.54
14.28
18.33
19.49
17.34
18.77
20.03
Revenue per Share
0.76
0.76
0.81
0.85
0.96
0.9
1.1
1.03
1.13
1.22
1.11
2.75
3.05
1.46
1.07
1.07
Basic EPS, GAAP
0.65
0.61
0.79
0.58
0.84
0.62
0.76
0.79
-0.78
-0.86
-0.7
-0.76
-0.79
-1.06
-1.22
-0.96
Free Cash Flow per Basic Share
0.59
0.59
0.59
0.52
0.65
0.7
0.53
0.68
0.57
0.83
0.87
0.89
0.98
1.04
1.17
1.18
Dividend per Share
6.79
6.96
7.23
7.61
8
8.23
8.95
9.32
9.83
11.73
11.37
13.42
15.08
15.75
16.16
16.01
Book Value per Share
-11.03
-10.79
-11.19
-12.01
-2.44
-13.16
-15.4
-3.49
-3.41
-17.22
-16.66
-13.77
-14.47
-15.41
-20.14
-2.69
Tangible Book Value per Share
388
388
390
395
400
401
410
417
422
449
475
477
478
470
476
480
Basic Weighted Avg Shares
2,945
3,064
3,307
3,425
3,855
4,141
4,947
5,054
5,476
6,076
6,783
8,753
9,321
8,145
8,934
9,619
Sales/Revenue/Turnover
13.58
13.99
13.79
13.12
13.47
11.16
11.31
11.39
11.51
11.52
11.24
21.93
22.93
12.21
9.14
9.41
Operating Margin (%)
108
115
132
141
161
179
220
228
256
273
606
642
675
703
777
815
Depreciation Expense
293
295
316
335
385
363
451
428
476
550
528
1,315
1,461
685
511
514
Net Income, GAAP
24.01
24.57
23.99
23.37
24.49
23.88
22.03
23.16
21.38
22.59
22.48
26.3
27.04
23.98
25.57
27.56
Effective Tax Rate (%)
9.96
9.61
9.56
9.78
9.99
8.77
9.12
8.46
8.69
9.05
7.78
15.02
15.67
8.41
5.72
5.34
Profit Margin (%)
-682
114
-933
-927
-108
208
-834
-311
-58
-1,415
-658
-1,144
-677
-598
-621
382
Working Capital
2,702
3,408
2,445
2,874
1,521
4,448
4,197
2,052
5,583
4,418
6,825
4,276
4,248
4,427
6,545
4,710
LT Debt
2,559
2,516
2,610
2,918
3,109
3,342
3,733
3,926
4,283
5,492
5,664
6,504
7,428
7,922
8,075
8,473
Total Equity
4.97
5.33
5.73
5.3
6.54
5.44
5.22
5.6
5.89
5
4.66
11.11
12.88
5.97
4.31
4.52
Return on Invested Capital (%)
5.55
5.64
6
5.74
7.03
6.14
5.86
5.91
6.32
5.71
4.86
10.84
12.44
5.99
4.31
4.06
Return on Capital (%)
11.36
11.04
11.45
11.5
12.4
11.17
12.94
11.32
11.84
11.68
9.9
22.28
21.45
9.38
6.77
6.68
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.99%
8.51%
4.93%
Free Cash Flow
-12.41%
8.2%
-20.16%
Net Income, GAAP
12.4%
16.45%
0.49%
Sales/Revenue/Turnover
9.28%
8.06%
7.67%
Total Cash Common Dividend
9.09%
6.68%
1.33%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
8,145
2024
- -
- -
- -
- -
8,934
2025
- -
- -
- -
- -
9,619

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.46
2024
- -
- -
- -
- -
1.07
2025
- -
- -
- -
- -
1.07

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.04
2024
- -
- -
- -
- -
1.17
2025
- -
- -
- -
- -
1.18
Similar Companies
PerkinElmer, Inc. (PKI)
Danaher Corporation (DHR-PB)
Thermo Fisher Scientific Inc. (TMO)
Precision System Science Co., Ltd. (PCNEF)
IQVIA Holdings Inc. (0JDM.L)
Precision System Science Co., Ltd. (7707.T)
Business
Sonic Healthcare Limited (ASX: SHL), headquartered in Sydney, Australia, and founded in 1987, ranks as one of the world's leading providers of medical diagnostic services, including pathology and clinical laboratory testing in disciplines such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology and molecular pathology; radiology and diagnostic imaging services; primary care through medical centres; and occupational health services. The company operates across Australia, New Zealand, the United States, the United Kingdom, Germany, Switzerland, Belgium and Ireland, where it holds the largest private pathology position in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third-largest in the US, employing approximately 45,000 people including 1,600 pathologists and radiologists. Sonic recently completed acquisitions in Germany, Switzerland, the UK and the US that contribute about A$700 million in additional annual revenue from FY25 alongside new contract wins, driving projected EBITDA growth to A$1.7-A$1.75 billion in FY25 and further margin expansion in FY26; reported FY25 revenue of A$9.6 billion and net profit of A$514 million; and announced Dr. Jim Newcombe as incoming CEO and Managing Director effective 20 November 2025, succeeding Dr. Colin Goldschmidt.